Loading…
Held by equity mutual funds in 26 disclosed months, Sep 2023 to Sep 2026.
NOVO NORDISK ADR REPSG 1 (Pharmaceuticals & Biotechnology) was held by 1 active equity mutual fund in September 2026, ₹11.3 Cr in all (up 0 funds from Aug 2026). The largest position was DSP Value Fund at 0.5% of its portfolio. During the month 0 funds entered and 0 exited. Funds have disclosed holding it since Sep 2023.
Weight is the share of that fund's portfolio; change is against the previous disclosed month.
None.
None.
None.
How many equity funds held the company each month, and the value they held.